Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2024-03-20 00:00:00 ET · period of report 2024-03-18 · accession 0001610717-24-000171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-03-20 | 2024-03-18 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $31.58 | -5,788 | 460.4K | -1% | -$182.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-18 | S | D | 5,788 | $31.58 | 460,379 | D | — | — | (F2) Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes. (F3) Includes 232,000 RSUs. |